210 filings
Page 3 of 11
8-K
xu61aezi
3 Mar 23
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
8:05am
8-K
psr188tdj3e
19 Jan 23
Entry into a Material Definitive Agreement
4:14pm
424B5
cxhgfih1o8bmxxkh1
19 Jan 23
Prospectus supplement for primary offering
4:05pm
8-K
mohdi622
10 Jan 23
Other Events
7:05am
S-8
44bxp0y4dciqy zxyf0p
4 Jan 23
Registration of securities for employees
4:13pm
8-K
gna2x5vj3p1wuo
27 Dec 22
Entry into a Material Definitive Agreement
4:13pm
8-K
2b8vqg0a
9 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
0fdcmsjz42pjgqw43
28 Nov 22
Entry into a Material Definitive Agreement
4:52pm
8-K
8abqksjkvnwc3t5
8 Nov 22
Kala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8:05am
8-K
slf6bg9j
1 Nov 22
Departure of Directors or Certain Officers
4:05pm
8-K
jsa8f2qk n88
20 Oct 22
Kala Pharmaceuticals Announces Reverse Stock Split
4:01pm
PRE 14A
zqtzcypc5e18z
30 Aug 22
Preliminary proxy
5:00pm
8-K
osy haiiw5h4906bnks
19 Aug 22
Kala Pharmaceuticals Announces Distribution of Series D Preferred Stock to Holders of its Common Stock
7:08am
8-A12G
593ru8
19 Aug 22
Registration of securities
7:00am
8-K
m6bj1va
11 Aug 22
Kala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:01am